查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468495

口服蛋白质和胜肽市场按药物类型（利那洛肽、普莱卡那肽、降钙素、胰岛素、奥曲肽）、应用（胃和消化疾病、骨骼疾病、糖尿病、荷尔蒙失调）和地区2024-2032

Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球口服蛋白和胜肽市场规模达到17亿美元。慢性病盛行率不断扩大、老年人口不断增加以及消费者对口服药物的日益偏好是推动市场发展的一些关键因素。

蛋白质和胜肽是人体的天然成分，在许多生物过程中发挥重要作用。由于其结构复杂且易于在胃和小肠中消化，因此通常透过注射给药。然而，口服蛋白质和胜肽可以透过口服途径摄取来治疗荷尔蒙、胃和代谢紊乱。它们旨在透过使用专门的配方来克服这些挑战，这些配方可以保护分子免受消化，并允许它们透过肠壁吸收到血液中。这些製剂包括肠溶衣、奈米颗粒和其他递送技术。口服蛋白质和胜肽广泛用于治疗多种慢性疾病，例如糖尿病、癌症和自体免疫疾病。

口服蛋白质和胜肽市场趋势：

患有癌症、糖尿病、心血管疾病（CVD）和后天免疫缺乏症候群（AID）等慢性疾病的患者数量不断增加，以及老年人口的不断扩大，是推动口服蛋白质和胜肽市场成长的关键因素。除此之外，大众偏好的转变以及对有效口服药物和技术的需求不断增长也促进了市场的成长。此外，消费者健康意识的不断增强以及对口服蛋白质和胜肽补充剂的众多益处的认识不断增强，正在为市场创造积极的前景。除此之外，三维（3D）列印、奈米技术和基因工程等创新技术进步使製造商能够生产更先进、更具成本效益的产品变体，这是另一个重要的成长诱导因素。同时，製药公司之间的广泛合作、医疗保健基础设施的重大进步以及不断增加的研发 (R&D) 活动为市场带来了丰厚的成长机会。此外，消费者可支配收入的增加，富含蛋白质的饮食的广泛采用，对蛋白粉、蛋白棒和奶昔的需求激增，以及提供便捷产品获取的在线平台的日益增多，都有助于市场扩张。

本报告回答的关键问题：

  • 迄今为止，全球口服蛋白质和胜肽市场表现如何，未来几年将如何表现？
  • 全球口服蛋白和胜肽市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球口服蛋白质和胜肽市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的口服蛋白质和胜肽市场？
  • 根据药物类型分類的市场是怎么样的？
  • 口服蛋白质和胜肽市场中最具吸引力的药物类型是什么？
  • 基于应用程式的市场区隔是什么？
  • 口服蛋白质和胜肽市场中哪一个应用最有吸引力？
  • 全球口服蛋白和胜肽市场的竞争结构如何？
  • 全球口服蛋白质和胜肽市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球口服蛋白质与胜肽市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类型

  • 利那洛肽
    • 市场走向
    • 市场预测
  • 普卡那肽
    • 市场走向
    • 市场预测
  • 降钙素
    • 市场走向
    • 市场预测
  • 胰岛素
    • 市场走向
    • 市场预测
  • 奥曲肽
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 胃和消化系统疾病
    • 市场走向
    • 市场预测
  • 骨骼疾病
    • 市场走向
    • 市场预测
  • 糖尿病
    • 市场走向
    • 市场预测
  • 荷尔蒙失调
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amryt Pharma Plc
    • AstraZeneca PLC
    • Biocon Limited
    • Novo Nordisk A/S
    • Oramed Ltd
    • Proxima Concepts Limited
Product Code: SR112024A7530

The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032. The expanding prevalence of chronic diseases, the rising geriatric population, and the increasing preference for oral drugs among consumers represent some of the key factors driving the market.

Proteins and peptides are natural components of the human body and play essential roles in many biological processes. Due to their complex structure and susceptibility to digestion in the stomach and small intestine, they are usually administered through injections. However, oral proteins and peptides can be taken via the oral path to treat hormonal, gastric, and metabolic disorders. They are designed to overcome these challenges by using specialized formulations that protect the molecules from digestion and allow them to be absorbed through the intestinal wall into the bloodstream. These formulations include enteric coatings, nanoparticles, and other delivery technologies. Oral proteins and peptides are extensively utilized to treat numerous chronic diseases, such as diabetes, cancer, and autoimmune disorders.

Oral Proteins and Peptides Market Trends:

The increasing volume of patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular disorders (CVDs), and acquired immunodeficiency syndrome (AIDs), and the expanding geriatric population represent the key factors driving the oral proteins and peptides market growth. Besides this, shifting preferences and the rising demand for effective oral drugs and technology among the masses are contributing to the market growth. Moreover, the escalating consumer health consciousness and the growing awareness of the numerous benefits associated with the consumption of oral protein and peptide supplements are creating a positive outlook for the market. In addition to this, innovative technological advancements, such as three-dimensional (3D) printing, nanotechnology, and genetic engineering, have enabled manufacturers to produce more advanced and cost-effective product variants, which is acting as another significant growth-inducing factor. Concurrent with this, the extensive collaborative efforts between pharmaceutical companies, significant advancements in the healthcare infrastructure, and rising research and development (R&D) activities are presenting remunerative growth opportunities for the market. Furthermore, the inflating disposable income of consumers, the widespread adoption of protein-rich diets, the surging demand for protein powder, bars, and shakes, and the increasing proliferation of online platforms providing easy product access are aiding in market expansion.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oral proteins and peptides market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug type and application.

Drug Type Insights:

Linaclotide

Plecanatide

Calcitonin

Insulin

Octreotide

The report has provided a detailed breakup and analysis of the oral proteins and peptides market based on the drug type. This includes linaclotide, plecanatide, calcitonin, insulin, and octreotide. According to the report, insulin represented the largest segment.

Application Insights:

Gastric and Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders

A detailed breakup and analysis of the oral proteins and peptides market based on the application has also been provided in the report. This includes gastric and digestive disorders, bone diseases, diabetes, and hormonal disorders. According to the report, diabetes accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral proteins and peptides. Some of the factors driving the North America oral proteins and peptides market included the increasing prevalence of chronic diseases, the shifting consumer preference for oral drugs, and innovative product advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral proteins and peptides market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global oral proteins and peptides market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global oral proteins and peptides market?
  • What is the impact of each driver, restraint, and opportunity on the global oral proteins and peptides market?
  • What are the key regional markets?
  • Which countries represent the most attractive oral proteins and peptides market?
  • What is the breakup of the market based on the drug type?
  • Which is the most attractive drug type in the oral proteins and peptides market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the oral proteins and peptides market?
  • What is the competitive structure of the global oral proteins and peptides market?
  • Who are the key players/companies in the global oral proteins and peptides market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oral Proteins and Peptides Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Linaclotide
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Plecanatide
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Calcitonin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Insulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Octreotide
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Gastric and Digestive Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormonal Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amryt Pharma Plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 AstraZeneca PLC
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biocon Limited
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Novo Nordisk A/S
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Oramed Ltd
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Proxima Concepts Limited
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
  • Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2023
  • Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
  • Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
  • Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
  • Table 6: Global: Oral Proteins and Peptides Market: Key Players